Price Alert

Cryo-Cell International I... (CCEL)

NASDAQ: CCEL · Real-Time Price · USD

4.11

-0.44 (-9.67%)

At close: Aug 14, 2025, 3:29 PM

4.33

5.35%

Pre-market: Aug 15, 2025, 04:09 AM EDT

Cryo-Cell International Statistics

Share Statistics

Cryo-Cell International has 8.06M shares outstanding. The number of shares has increased by 0.25% in one year.

Shares Outstanding	8.06M
Shares Change (YoY)	0.25%
Shares Change (QoQ)	0%
Owned by Institutions (%)	12.75%
Shares Floating	4.39M
Failed to Deliver (FTD) Shares	62
FTD / Avg. Volume	0.59%

Short Selling Information

The latest short interest is 8.21K, so 0.1% of the outstanding shares have been sold short.

Short Interest	8.21K
Short % of Shares Out	0.1%
Short % of Float	0.15%
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is 175.31 and the forward PE ratio is -81.42. Cryo-Cell International's PEG ratio is -1.68.

PE Ratio	175.31
Forward PE	-81.42
PS Ratio	2.2
Forward PS	1.2
PB Ratio	-5.33
P/FCF Ratio	19.54
PEG Ratio	-1.68

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cryo-Cell International.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.58, with a Debt / Equity ratio of -0.98.

Current Ratio	0.58
Quick Ratio	0.55
Debt / Equity	-0.98
Debt / EBITDA	9.09
Debt / FCF	3.59
Interest Coverage	1.87

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$390.07K
Profits Per Employee	$4.9K
Employee Count	82
Asset Turnover	0.49
Inventory Turnover	12.08

Taxes

Income Tax	2.4M
Effective Tax Rate	85.66%

Stock Price Statistics

The stock price has increased by -27.79% in the last 52 weeks. The beta is 0.73, so Cryo-Cell International's price volatility has been higher than the market average.

Beta	0.73
52-Week Price Change	-27.79%
50-Day Moving Average	5.03
200-Day Moving Average	6.48
Relative Strength Index (RSI)	48.01
Average Volume (20 Days)	10,461

Income Statement

In the last 12 months, Cryo-Cell International had revenue of 31.99M and earned 402.1K in profits. Earnings per share was 0.05.

Revenue	31.99M
Gross Profit	24.04M
Operating Income	3.48M
Net Income	402.1K
EBITDA	1.42M
EBIT	939.44K
Earnings Per Share (EPS)	0.05

Full Income Statement

Balance Sheet

The company has 560.96K in cash and 12.93M in debt, giving a net cash position of -12.37M.

Cash & Cash Equivalents	560.96K
Total Debt	12.93M
Net Cash	-12.37M
Retained Earnings	-32.78M
Total Assets	64.44M
Working Capital	-8.7M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.01M and capital expenditures -2.4M, giving a free cash flow of 3.61M.

Operating Cash Flow	6.01M
Capital Expenditures	-2.4M
Free Cash Flow	3.61M
FCF Per Share	0.44

Full Cash Flow Statement

Margins

Gross margin is 75.15%, with operating and profit margins of 10.88% and 1.26%.

Gross Margin	75.15%
Operating Margin	10.88%
Pretax Margin	8.77%
Profit Margin	1.26%
EBITDA Margin	4.45%
EBIT Margin	10.88%
FCF Margin	11.28%

Dividends & Yields

CCEL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for CCEL is $8.5, which is 73.1% higher than the current price. The consensus rating is "Buy".

Price Target	$8.5
Price Target Difference	73.1%
Analyst Consensus	Buy
Analyst Count	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$0.25
Lynch Upside	-94.91%
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-0.03
Piotroski F-Score	7